300158 Stock Overview
Engages in the research and development, production, and sales of pharmaceutical drugs in China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Shanxi Zhendong Pharmaceutical Co.,Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥4.50 |
| 52 Week High | CN¥7.00 |
| 52 Week Low | CN¥3.13 |
| Beta | 0.40 |
| 1 Month Change | -10.18% |
| 3 Month Change | 0.22% |
| 1 Year Change | -33.33% |
| 3 Year Change | -45.05% |
| 5 Year Change | -4.66% |
| Change since IPO | -53.88% |
Recent News & Updates
Improved Revenues Required Before Shanxi Zhendong Pharmaceutical Co.,Ltd (SZSE:300158) Stock's 39% Jump Looks Justified
Oct 22
We Think Shanxi Zhendong PharmaceuticalLtd (SZSE:300158) Can Afford To Drive Business Growth
Sep 30Recent updates
Improved Revenues Required Before Shanxi Zhendong Pharmaceutical Co.,Ltd (SZSE:300158) Stock's 39% Jump Looks Justified
Oct 22We Think Shanxi Zhendong PharmaceuticalLtd (SZSE:300158) Can Afford To Drive Business Growth
Sep 30Shanxi Zhendong Pharmaceutical Co.,Ltd's (SZSE:300158) Low P/S No Reason For Excitement
Aug 08Shanxi Zhendong Pharmaceutical Co.,Ltd (SZSE:300158) Surges 31% Yet Its Low P/S Is No Reason For Excitement
Mar 07Shareholder Returns
| 300158 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -6.4% | -1.9% | -0.6% |
| 1Y | -33.3% | -5.7% | 8.3% |
Return vs Industry: 300158 underperformed the CN Pharmaceuticals industry which returned -5.7% over the past year.
Return vs Market: 300158 underperformed the CN Market which returned 8.3% over the past year.
Price Volatility
| 300158 volatility | |
|---|---|
| 300158 Average Weekly Movement | 9.2% |
| Pharmaceuticals Industry Average Movement | 7.3% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.9% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 300158 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 300158's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 3,576 | Lianmin Yang | www.zdjt.com |
Shanxi Zhendong Pharmaceutical Co.,Ltd, together with its subsidiaries, engages in the research and development, production, and sales of pharmaceutical drugs in China and internationally. It offers drugs for various fields, including cancer, cardiovascular, infectious disease, antibiotics, cardiocerebrovascular, antitumor, gastrointestinal, and respiratory, as well as urinary, tonic, dermatology, blood hematopoietic, digestion, urology, and heart and brain; vitamins; Chinese medicines in the form of pills, tablets, capsules, powders, and granules, as well as herbal medicines; and food and beverages for various health applications. The company engages in the pharmaceutical wholesale and logistics distribution business; tending, planting, processing, storage, and decoction of seedlings for medication applications; and offers home care and personal care products.
Shanxi Zhendong Pharmaceutical Co.,Ltd Fundamentals Summary
| 300158 fundamental statistics | |
|---|---|
| Market cap | CN¥4.52b |
| Earnings (TTM) | -CN¥2.99m |
| Revenue (TTM) | CN¥3.11b |
1.5x
P/S Ratio-1,515x
P/E RatioIs 300158 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300158 income statement (TTM) | |
|---|---|
| Revenue | CN¥3.11b |
| Cost of Revenue | CN¥1.57b |
| Gross Profit | CN¥1.54b |
| Other Expenses | CN¥1.54b |
| Earnings | -CN¥2.99m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.003 |
| Gross Margin | 49.43% |
| Net Profit Margin | -0.096% |
| Debt/Equity Ratio | 0% |
How did 300158 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/29 02:53 |
| End of Day Share Price | 2024/12/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Shanxi Zhendong Pharmaceutical Co.,Ltd is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Wenchao Jiao | Ping An Securities Co. Ltd. |
| Yin Ye | Ping An Securities Co. Ltd. |
| Wen Qing Wei | Shenwan Hongyuan Securities |